Medicago signs agreements with the government of Canada to supply up to 76 million doses of its recombinant plant-derived COVID-19 vaccine
Read more
-
-
Medicago begins phase 1 clinical trials for its COVID-19 vaccine candidate
Read more -
Dynavax and Medicago announce collaboration to develop a novel adjuvanted COVID-19 vaccine candidate
Read more -
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
Read more -
Medicago announces positive results in animal trials for its vaccine candidate against COVID-19
Read more -
Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D
Read more -
Government of Canada providing financial support towards Medicago’s COVID-19 vaccine development
Read more -
Government of Quebec providing $7 Million towards Medicago’s COVID-19 vaccine development
Read more -
Medicago announces production of a viable vaccine candidate for COVID-19
Read more -
A Medicago employee named one of CASCON X Evoke Canada’s Tech Titans: Top 19 of 2019
Read more -
Medicago awarded « Best New Vaccine Technology/Platform » at the World Vaccine Congress
Read more -
Medicago officially starts the construction of its site in Estimauville’s Innovation Area
Read more